Resistant Hypertension in the High-Risk Metabolic Patient
- 13 October 2010
- journal article
- review article
- Published by Springer Nature in Current Diabetes Reports
- Vol. 11 (1) , 41-46
Abstract
The metabolic syndrome is a constellation of metabolic and vascular abnormalities that include insulin resistance with compensatory hyperinsulinemia, central or visceral obesity, hypertension, dyslipidemia, microalbuminuria, and oxidative stress as well as prothrombotic and inflammatory abnormalities that contribute to a hypercoagulable state and systemic endothelial dysfunction. Visceral adipose tissue is now known to secrete into the circulation a number of protein and nonprotein factors that regulate glucose metabolism in traditional insulin-sensitive tissue as well as nontraditional insulin-sensitive tissue including cardiovascular tissue. Collectively, this constellation of factors that lead to metabolic dysregulation contributes to a substantial risk for adverse cardiovascular and renal outcomes. The development of a particularly resistant form of hypertension in these individuals can be attributed to a number of factors including vasoconstriction from increased sympathetic activation, proinflammatory cytokines, and inappropriate activation of the renin-angiotensin-aldosterone system. The management of hypertension in such patients can be challenging and generally requires nonpharmacologic as well as pharmacologic interventions.Keywords
This publication has 67 references indexed in Scilit:
- Obesity-induced Hypertension: Role of Sympathetic Nervous System, Leptin, and MelanocortinsJournal of Biological Chemistry, 2010
- Brain cytokines as neuromodulators in cardiovascular controlClinical and Experimental Pharmacology and Physiology, 2010
- Pathogenesis and Pathophysiology of the Cardiometabolic SyndromeThe Journal of Clinical Hypertension, 2009
- Mineralocorticoid receptor antagonism attenuates glomerular filtration barrier remodeling in the transgenic Ren2 ratAmerican Journal of Physiology-Renal Physiology, 2009
- Interaction of Aldosterone and Extracellular Volume in the Pathogenesis of Obesity-Associated Kidney Disease: A Narrative ReviewAmerican Journal of Nephrology, 2009
- Mechanisms mediating renal sympathetic activation to leptin in obesityAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008
- Aldosterone and Vascular InflammationHypertension, 2008
- Adipocytokines: mediators linking adipose tissue, inflammation and immunityNature Reviews Immunology, 2006
- Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndromeJournal of Clinical Investigation, 2006
- Adiponectin Replenishment Ameliorates Obesity-Related HypertensionHypertension, 2006